TG Therapeutics ROE 2006-2020 | TGTX

Current and historical return on equity (ROE) values for TG Therapeutics (TGTX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. TG Therapeutics ROE for the three months ending March 31, 2020 was -2937.74%.
TG Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $-0.19B $-0.00B -3024.00%
2019-12-31 $-0.17B $0.04B -1537.78%
2019-09-30 $-0.19B $-0.03B -2493.33%
2019-06-30 $-0.16B $0.01B -496.88%
2019-03-31 $-0.17B $0.02B -309.26%
2018-12-31 $-0.17B $0.02B -246.81%
2018-09-30 $-0.15B $0.07B -185.85%
2018-06-30 $-0.15B $0.10B -178.98%
2018-03-31 $-0.13B $0.09B -171.61%
2017-12-31 $-0.12B $0.07B -146.01%
2017-09-30 $-0.11B $0.08B -151.86%
2017-06-30 $-0.11B $0.08B -154.41%
2017-03-31 $-0.09B $0.10B -136.26%
2016-12-31 $-0.08B $0.04B -121.07%
2016-09-30 $-0.07B $0.06B -89.30%
2016-06-30 $-0.06B $0.08B -64.25%
2016-03-31 $-0.06B $0.09B -60.00%
2015-12-31 $-0.06B $0.10B -58.58%
2015-09-30 $-0.07B $0.12B -62.65%
2015-06-30 $-0.07B $0.11B -74.32%
2015-03-31 $-0.06B $0.11B -82.62%
2014-12-31 $-0.06B $0.08B -88.54%
2014-09-30 $-0.04B $0.07B -80.75%
2014-06-30 $-0.03B $0.05B -64.92%
2014-03-31 $-0.03B $0.05B -69.80%
2013-12-31 $-0.02B $0.04B -80.00%
2013-09-30 $-0.02B $0.05B -88.37%
2013-06-30 $-0.02B $0.01B -108.47%
2013-03-31 $-0.01B $0.02B -63.77%
2012-12-31 $-0.02B $0.02B -90.67%
2012-09-30 $-0.02B $0.02B -104.35%
2012-06-30 $-0.02B $0.02B -125.49%
2012-03-31 $-0.01B $0.02B -193.10%
2011-12-31 $0.00B $0.01B 0.00%
2011-09-30 $0.00B $0.00B -200.00%
2011-06-30 $0.00B $-0.00B -114.29%
2011-03-31 $0.01B $-0.00B -133.33%
2010-12-31 $0.00B $-0.01B 0.00%
2010-09-30 $0.00B $-0.01B 0.00%
2010-06-30 $0.00B $-0.01B 0.00%
2010-03-31 $-0.00B $-0.01B 42.86%
2009-12-31 $-0.00B $-0.01B 32.00%
2009-09-30 $-0.00B $-0.01B 36.36%
2009-06-30 $-0.00B $-0.01B 60.00%
2009-03-31 $-0.00B $-0.01B 70.59%
2008-12-31 $-0.00B $-0.00B 133.33%
2008-09-30 $-0.01B $-0.01B 266.67%
2008-06-30 $-0.01B $-0.00B 1066.67%
2008-03-31 $-0.01B $0.00B -1600.00%
2007-12-31 $-0.01B $-0.00B -520.00%
2007-09-30 $-0.01B $0.00B -430.77%
2007-06-30 $-0.01B $0.00B -325.00%
2007-03-31 $-0.01B $0.01B -222.22%
2006-12-31 $-0.01B $0.00B -200.00%
2006-09-30 $-0.01B $0.00B -123.08%
2006-06-30 $-0.01B $0.01B -96.97%
2006-03-31 $-0.02B $0.01B -262.07%
2005-12-31 $-0.02B $0.01B -304.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.055B $0.000B
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $167.899B 29.12
Medtronic (MDT) Ireland $132.114B 21.48
Stryker (SYK) United States $73.365B 23.81
Boston Scientific (BSX) United States $53.161B 24.99
Baxter (BAX) United States $45.654B 27.87
Lonza Group Ag (LZAGY) Switzerland $36.676B 0.00
Terumo (TRUMY) Japan $29.978B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.400B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.077B 16.41
ResMed (RMD) United States $23.266B 36.72
Smith & Nephew SNATS (SNN) United Kingdom $17.849B 0.00
Sunny Optical Technology (SNPTF) China $14.583B 0.00
Bio-Rad Laboratories (BIO) United States $14.566B 66.30
Insulet (PODD) United States $11.896B 1178.56
DiaSorin S.p.A (DSRLF) Italy $10.630B 0.00
Perrigo (PRGO) Ireland $7.466B 13.36
Quidel (QDEL) United States $7.350B 57.76
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Hill-Rom Holdings (HRC) United States $6.767B 19.08
William Demant Holdings (WILYY) Denmark $6.670B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Canopy Growth (CGC) Canada $6.093B 0.00
Haemonetics (HAE) United States $5.517B 33.14
ICU Medical (ICUI) United States $4.158B 30.34
GW Pharmaceuticals (GWPH) United Kingdom $3.796B 0.00
Neogen (NEOG) United States $3.754B 63.59
Agios Pharmaceuticals (AGIO) United States $3.564B 0.00
Envista Holdings (NVST) United States $3.366B 0.00
NuVasive (NUVA) United States $3.106B 24.94
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.909B 0.00
National Vision Holdings (EYE) United States $2.150B 37.19
AtriCure (ATRC) United States $1.916B 0.00
Aurora Cannabis (ACB) Canada $1.428B 0.00
Cardiovascular Systems (CSII) United States $1.366B 0.00
NanoString Technologies (NSTG) United States $1.152B 0.00
Aphria (APHA) Canada $1.130B 0.00
Phibro Animal Health (PAHC) United States $1.060B 21.13
Cerus (CERS) United States $1.020B 0.00
MacroGenics (MGNX) United States $0.945B 0.00
InMode (INMD) Israel $0.937B 19.80
OraSure Technologies (OSUR) United States $0.902B 181.75
PetIQ (PETQ) United States $0.871B 25.15
Omeros (OMER) United States $0.811B 0.00
Quanterix (QTRX) United States $0.781B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.735B 124.46
VAREX IMAGING (VREX) United States $0.734B 18.21
Eagle Pharmaceuticals (EGRX) United States $0.701B 50.25
Meridian Bioscience (VIVO) United States $0.662B 24.94
Zynex (ZYXI) United States $0.644B 64.67
Vapotherm (VAPO) United States $0.567B 0.00
Lantheus Holdings (LNTH) United States $0.546B 10.98
LeMaitre Vascular (LMAT) United States $0.543B 30.91
Surmodics (SRDX) United States $0.503B 60.62
Owens & Minor (OMI) United States $0.500B 13.22
Repro-Med Systems (KRMD) United States $0.402B 337.33
Cytosorbents (CTSO) United States $0.370B 0.00
Utah Medical Products (UTMD) United States $0.362B 26.32
BioLife Solutions (BLFS) United States $0.336B 149.55
Viemed Healthcare (VMD) United States $0.321B 28.72
Organigram Holdings (OGI) Canada $0.306B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.283B 0.00
HEXO (HEXO) $0.258B 0.00
Female Health (VERU) United States $0.247B 0.00
InfuSystems Holdings (INFU) United States $0.233B 129.00
Chimerix (CMRX) United States $0.193B 0.00
Chembio Diagnostics (CEMI) United States $0.169B 0.00
Evolus (EOLS) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 13.66
Bovie Medical (APYX) United States $0.152B 0.00
Rockwell Medical (RMTI) United States $0.148B 0.00
Exagen (XGN) United States $0.146B 0.00
Surface Oncology (SURF) United States $0.145B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.127B 0.00
MTech Acquisition (KERN) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.109B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Wound Management Technologies (SMTI) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.073B 0.00
United-Guardian (UG) United States $0.072B 16.77
Nephros (NEPH) United States $0.070B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00